Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Colorectal Neoplasms

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 121 articles:
HTML format



Single Articles


    January 2022
  1. HWANG J, Park A, Kim C, Yu D, et al
    Suppression of DYRK1A/B Drives Endoplasmic Reticulum Stress-mediated Autophagic Cell Death Through Metabolic Reprogramming in Colorectal Cancer Cells.
    Anticancer Res. 2022;42:589-598.
    PubMed     Abstract available


  2. MIYOSHI K, Sato E, Katsumata K, Fukushima G, et al
    CD15(+) Bone Marrow-derived Cells Are Regulators of Immune Response in ARG1-producing Colorectal Cancer Cells.
    Anticancer Res. 2022;42:459-470.
    PubMed     Abstract available


  3. MULLER O, Sindayigaya R, Chomicki S, Karam E, et al
    Prognostic Impact of Upfront Surgery for Locally Advanced Upper Rectal Adenocarcinoma.
    Anticancer Res. 2022;42:155-164.
    PubMed     Abstract available


  4. MIYATA H, Akiyama Y, Iizuka A, Kondou R, et al
    Development of an Automatic Measurement Method for CD8 and PD-1 Positive T Cells Using Image Analysis Software.
    Anticancer Res. 2022;42:419-427.
    PubMed     Abstract available


  5. BRESCIA A, Muttillo EM, Angelicone I, Madaffari I, et al
    The Role of Indocyanine Green in Laparoscopic Low Anterior Resections for Rectal Cancer Previously Treated With Chemo-radiotherapy: A Single-center Retrospective Analysis.
    Anticancer Res. 2022;42:211-216.
    PubMed     Abstract available


    December 2021
  6. SHIBUTANI M, En W, Okazaki Y, Kashiwagi S, et al
    The Efficacy and Safety of Trifluridine/Tipiracil Treatment for Elderly Patients With Metastatic Colorectal Cancer in a Real-world Setting.
    Anticancer Res. 2021;41:6211-6216.
    PubMed     Abstract available


  7. ZENG X, Zhang L, Jia S, Lin T, et al
    Effects of Circulating 25(OH)D Status in Advanced Colorectal Cancer Patients Undergoing Chemotherapy: A Systematic Review.
    Anticancer Res. 2021;41:5903-5912.
    PubMed     Abstract available


  8. MATSUHASHI N, Takahashi T, Tanaka C, Yawata K, et al
    Phase II Study of Preoperative Chemoradiotherapy With S-1 Plus Oxaliplatin for Locally Advanced Rectal Cancer (PerSeUS-RC01).
    Anticancer Res. 2021;41:6247-6257.
    PubMed     Abstract available


    November 2021
  9. MAZAKI J, Katsumata K, Ohno Y, Udo R, et al
    A Novel Predictive Model for Anastomotic Leakage in Colorectal Cancer Using Auto-artificial Intelligence.
    Anticancer Res. 2021;41:5821-5825.
    PubMed     Abstract available


  10. KAWAMURA H, Honda M, Takiguchi K, Kamiga T, et al
    Clinical Impact of Primary Tumor Site in Stage IV Colorectal Cancer: A Statewide Cohort Study.
    Anticancer Res. 2021;41:5693-5702.
    PubMed     Abstract available


  11. TAGO T, Katsumata K, Udou R, Kasahara K, et al
    Significance of Radiofrequency Ablation for Unresectable Colorectal Cancer With Liver Metastases.
    Anticancer Res. 2021;41:5539-5547.
    PubMed     Abstract available


  12. ISHIZAWA M, Hirayu A, Makishima M
    Zinc Inhibits Cadherin 1 Expression Induced by 1alpha,25-Dihydroxyvitamin D3 in Colon Cancer Cells.
    Anticancer Res. 2021;41:5453-5459.
    PubMed     Abstract available


  13. SUZUMURA H, Tsuruta M, Okabayashi K, Shigeta K, et al
    BAF57 Is a Potential Determinant of Colorectal Cancer Malignancy.
    Anticancer Res. 2021;41:5445-5452.
    PubMed     Abstract available


  14. ROH SA, Kwon YH, Lee JL, Kim SK, et al
    SLAMF7 and TREM1 Mediate Immunogenic Cell Death in Colorectal Cancer Cells: Focus on Microsatellite Stability.
    Anticancer Res. 2021;41:5431-5444.
    PubMed     Abstract available


  15. ADACHI Y, Yamamura K, Yumoto S, Higashi T, et al
    Far-advanced Colorectal Liver Metastases Successfully Managed With Modified ALPPS and Radiofrequency Ablation in Combination With Chemotherapy.
    Anticancer Res. 2021;41:5855-5861.
    PubMed     Abstract available


  16. AKAHOSHI S, Yamamura K, Komohara Y, Yoshii D, et al
    A Case Report of Metachronous Multiple Adenosquamous Carcinoma of the Colon Over-expressing PD-L1 and a Literature Review.
    Anticancer Res. 2021;41:5847-5854.
    PubMed     Abstract available


  17. FURUKAWA K, Onda S, Taniai T, Hamura R, et al
    Risk Factors and Overcoming Strategies of Surgical Site Infection After Hepatectomy for Colorectal Liver Metastases.
    Anticancer Res. 2021;41:5651-5656.
    PubMed     Abstract available


  18. MASATSUNE S, Kimura K, Kashiwagi S, En W, et al
    Impact of Intraoperative Blood Loss and Blood Transfusion on the Prognosis of Colorectal Liver Metastasis Following Curative Resection.
    Anticancer Res. 2021;41:5617-5623.
    PubMed     Abstract available


  19. OKAMOTO D, Matsuda T, Sawada R, Hasegawa H, et al
    Risk Factors for Complications Following Lateral Pelvic Lymph Node Dissection for Rectal Cancer.
    Anticancer Res. 2021;41:5599-5604.
    PubMed     Abstract available


  20. MEKLIN J, Eskelinen M, Guimaraes DP, Selander T, et al
    The Automatically Analyzed (AA) ColonView (CV) Quick Test for Fecal Occult Blood Shows Higher Diagnostic Accuracy in Detection of Colorectal Adenoma than Visually Analyzed Tests.
    Anticancer Res. 2021;41:5517-5525.
    PubMed     Abstract available


    October 2021
  21. SATO S, Shiozawa M, Nukada S, Iguchi K, et al
    Preoperative Pre-albumin Concentration as a Predictor of Short-term Outcomes in Elderly Patients With Colorectal Cancer.
    Anticancer Res. 2021;41:5195-5202.
    PubMed     Abstract available


  22. ATSUMI Y, Numata M, Kazama K, Kawahara S, et al
    Can D3 Lymph Node Dissection for Patients With Colon Cancer With a Poor C-Reactive Protein/Albumin Ratio Improve Survival Outcomes?
    Anticancer Res. 2021;41:5097-5106.
    PubMed     Abstract available


  23. MEKLIN J, Eskelinen M, Guimaraes DP, Selander T, et al
    The New Generation Immunochemical Test for Fecal Occult Blood (ColonView Quick Test) Shows a High Diagnostic Accuracy in Colorectal Cancer Detection.
    Anticancer Res. 2021;41:5071-5079.
    PubMed     Abstract available


  24. NEUPANE P, Mimura K, Nakajima S, Okayama H, et al
    The Expression of Immune Checkpoint Receptors and Ligands in the Colorectal Cancer Tumor Microenvironment.
    Anticancer Res. 2021;41:4895-4905.
    PubMed     Abstract available


  25. TADA Y, Matsumi Y, Hara K, Miyauchi W, et al
    Infiltration of CD204-overexpressing Macrophages Contributes to the Progression of Stage II and III Colorectal Cancer.
    Anticancer Res. 2021;41:4857-4865.
    PubMed     Abstract available


  26. MIYAMOTO S, Fukui T, Horitani S, Tanimura Y, et al
    Linker Threonine-phosphorylated Smad2/3 Is a Biomarker of Colorectal Neoplastic Stem-like Cells that Correlates With Carcinogenesis.
    Anticancer Res. 2021;41:4789-4799.
    PubMed     Abstract available


  27. OZLUK E, Coppola D, Mohammad IZ, Islam T, et al
    Ethylmalonic Encephalopathy 1 Protein Is Increased in Colorectal Adenocarcinoma.
    Anticancer Res. 2021;41:4719-4723.
    PubMed     Abstract available


  28. SATO K, Miura T, Sakamoto Y, Morohashi H, et al
    Fascial Organisation and Lymphatic Systems Around the Pelvic Floor: A Literature Review.
    Anticancer Res. 2021;41:4705-4714.
    PubMed     Abstract available


  29. IIDA T, Murono K, Shiratori H, Nozawa H, et al
    Impact of Inferior Mesenteric Artery Occlusion on the Calibre of Collateral Arteries of the Colon.
    Anticancer Res. 2021;41:5189-5193.
    PubMed     Abstract available


  30. CHUNG YC, Ku YL, Chiang HC, Liu WC, et al
    Antibody to Interleukin-6 Receptor Inhibits In Vivo Growth of Human Colorectal Carcinoma Cell Xenografts.
    Anticancer Res. 2021;41:4907-4916.
    PubMed     Abstract available


    September 2021
  31. KIM CW, Ha YJ, Tak KH, Roh SA, et al
    Clinically Applicable Serum Biomarkers Among 14 Candidates Associated With Recurrence of Stage II and III Colorectal Cancer.
    Anticancer Res. 2021;41:4651-4658.
    PubMed     Abstract available


  32. KIM HB, Lee SB, Kim SJ, Lee HJ, et al
    Jagged-1 Expression Level Is Correlated With Recurrence of Stage III Colorectal Cancer in Patients Receiving Adjuvant Chemotherapy.
    Anticancer Res. 2021;41:4645-4650.
    PubMed     Abstract available


  33. MAZAKI J, Katsumata K, Ohno Y, Udo R, et al
    A Novel Prediction Model for Colon Cancer Recurrence Using Auto-artificial Intelligence.
    Anticancer Res. 2021;41:4629-4636.
    PubMed     Abstract available


  34. SHIBUTANI M, Maeda K, Kashiwagi S, Hirakawa K, et al
    The Impact of Intraoperative Blood Loss on the Survival After Laparoscopic Surgery for Colorectal Cancer.
    Anticancer Res. 2021;41:4529-4534.
    PubMed     Abstract available


  35. KIM HK, Yang Y, Byeon S, Jeong Y, et al
    E-Cadherin and Angiopoietin-2 as Potential Biomarkers for Colorectal Cancer With Peritoneal Carcinomatosis.
    Anticancer Res. 2021;41:4497-4504.
    PubMed     Abstract available


  36. NAGASAWA S, Tsuchida K, Shiozawa M, Hiroshima Y, et al
    Clinical Significance of Chemokine Receptor CXCR4 and CCR7 mRNA Expression in Patients With Colorectal Cancer.
    Anticancer Res. 2021;41:4489-4495.
    PubMed     Abstract available


  37. MAZAKI J, Katsumata K, Sujino H, Udo R, et al
    Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Colon Cancer in Elderly Patients: A Propensity Score Analysis.
    Anticancer Res. 2021;41:4471-4478.
    PubMed     Abstract available


  38. SHIBUTANI M, Nakao S, Maeda K, Nagahara H, et al
    The Impact of Tumor-associated Macrophages on Chemoresistance via Angiogenesis in Colorectal Cancer.
    Anticancer Res. 2021;41:4447-4453.
    PubMed     Abstract available


  39. SHIN MW, Kim SL, Yang HC, Yim SK, et al
    The HDAC1 Inhibitor CBUD-1001 Enhances TRAIL-induced Apoptosis in Colorectal Cancer Cells.
    Anticancer Res. 2021;41:4353-4364.
    PubMed     Abstract available


  40. KOYAMA M, Osada E, Takemura Y, Saito H, et al
    Gelatin Sponge as an Anchorage for Three-dimensional Culture of Colorectal Cancer Cells.
    Anticancer Res. 2021;41:4259-4269.
    PubMed     Abstract available


  41. TOKUDA K, Morine Y, Miyazaki K, Yamada S, et al
    Frailty Can Predict Prognosis After Hepatectomy in Patients With Colorectal Liver Metastasis.
    Anticancer Res. 2021;41:4637-4644.
    PubMed     Abstract available


  42. OKAMOTO H, Shiba S, Iino H, Sudoh M, et al
    Tumor Vascular Microenvironment of Colorectal Hepatic Metastasis and Chemotherapy Response.
    Anticancer Res. 2021;41:4505-4513.
    PubMed     Abstract available


  43. RADES D, Kopelke S, Bartscht T, Schild SE, et al
    Evaluation of Pre-radiotherapy Sleep Disorders in Patients With Rectal or Anal Cancer.
    Anticancer Res. 2021;41:4439-4442.
    PubMed     Abstract available


    August 2021
  44. SATO T, Osumi H, Shinozaki E, Ooki A, et al
    Clinical Impact of Primary Tumor Location and RAS, BRAF V600E, and PIK3CA Mutations on Epidermal Growth Factor Receptor Inhibitor Efficacy as Third-line Chemotherapy for Metastatic Colorectal Cancer.
    Anticancer Res. 2021;41:3905-3915.
    PubMed     Abstract available


  45. HASHIMOTO S, Nagai M, Nishi K, Ishikura S, et al
    Growth Suppression of Cancer Spheroids With Mutated KRAS by Low-toxicity Compounds from Natural Products.
    Anticancer Res. 2021;41:4061-4070.
    PubMed     Abstract available


  46. JANG BS, Song C, Kang SB, Kim JS, et al
    Radiogenomic and Deep Learning Network Approaches to Predict KRAS Mutation from Radiotherapy Plan CT.
    Anticancer Res. 2021;41:3969-3976.
    PubMed     Abstract available


  47. CAO W, Wang Q, Huang C
    Let-7a Inhibits Tumor Metastasis by Regulating TGF-beta/Smad Signaling in the Colorectal Adenocarcinoma Cell Line LS-174T.
    Anticancer Res. 2021;41:3801-3808.
    PubMed     Abstract available


    July 2021
  48. KIM J, Baek DW, Baek JH, Kang BW, et al
    Clinical Impact of Postoperative Vitamin D Deficiency on the Recurrence of Colon Cancer After Curative Surgical Resection.
    Anticancer Res. 2021;41:3683-3688.
    PubMed     Abstract available


  49. KUBO H, Ikoma H, Yamamoto Y, Morimura R, et al
    Therapeutic Strategy of Colorectal Liver Metastasis Using Modified-JHBPS Nomogram.
    Anticancer Res. 2021;41:3657-3665.
    PubMed     Abstract available


  50. SHIBUTANI M, Maeda K, Kashiwagi S, Hirakawa K, et al
    Effect of Adjuvant Chemotherapy on Survival of Elderly Patients With Stage III Colorectal Cancer.
    Anticancer Res. 2021;41:3615-3624.
    PubMed     Abstract available


  51. HIROSHIMA Y, Ishikawa H, Murakami M, Nakamura M, et al
    Proton Beam Therapy for Local Recurrence of Rectal Cancer.
    Anticancer Res. 2021;41:3589-3595.
    PubMed     Abstract available


  52. CHEN IY, Findeis-Hosey JJ, Cannon L, Liao X, et al
    Primary Colonic Medullary Carcinoma With Exclusive Squamous Differentiation.
    Anticancer Res. 2021;41:3567-3572.
    PubMed     Abstract available


  53. SHIBUTANI M, Maeda K, Kashiwagi S, Nagahara H, et al
    Lactate Dehydrogenase Is a Useful Marker for Predicting the Efficacy of Bevacizumab-containing Chemotherapy in Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2021;41:3535-3542.
    PubMed     Abstract available


  54. RUBIO CA, Schmidt PT
    Crypts in Asymmetric Fission in Endoscopic Biopsies from Swedish Patients With Inflammatory Bowel Disease.
    Anticancer Res. 2021;41:3511-3517.
    PubMed     Abstract available


  55. LIM JH, Go G, Lee SH
    PrPC Regulates the Cancer Stem Cell Properties via Interaction With c-Met in Colorectal Cancer Cells.
    Anticancer Res. 2021;41:3459-3470.
    PubMed     Abstract available


  56. MATSUI H, Homma S, Hatanaka KC, Sawada A, et al
    Novel Prognostic Stratification Factor Based on the Pathological Profile of the Invasive Front in Colorectal Cancer.
    Anticancer Res. 2021;41:3429-3438.
    PubMed     Abstract available


  57. DE ANGELIS PM, Dorg L, Pham S, Andersen SN, et al
    DNA Repair Protein Expression and Oxidative/Nitrosative Stress in Ulcerative Colitis and Sporadic Colorectal Cancer.
    Anticancer Res. 2021;41:3261-3270.
    PubMed     Abstract available


    June 2021
  58. KURAMOCHI H, Yamada T, Yoshida Y, Matsuda A, et al
    The Pre-treatment Lymphocyte-to-Monocyte Ratio Predicts Efficacy in Metastatic Colorectal Cancer Treated With TAS-102 and Bevacizumab.
    Anticancer Res. 2021;41:3131-3137.
    PubMed     Abstract available


  59. KIMURA M, Usami E, Teramachi H, Yoshimura T, et al
    Risk-benefit Analysis of FOLFIRI Plus Ramucirumab/Aflibercept as a Third-line Treatment in Metastatic Colorectal Cancer.
    Anticancer Res. 2021;41:3091-3097.
    PubMed     Abstract available


  60. KEENAN BP, VAN Loon K, Khilnani AD, Fidelman N, et al
    Molecular and Radiological Features of Microsatellite Stable Colorectal Cancer Cases With Dramatic Responses to Immunotherapy.
    Anticancer Res. 2021;41:2985-2992.
    PubMed     Abstract available


  61. DE FELICE F, Fallarino A, Iafrate F, Maiuri V, et al
    The INCH Trial - Induction Chemotherapy in Patients With Bulky Anal Canal Cancer: Evaluation of the Pilot Phase.
    Anticancer Res. 2021;41:3187-3191.
    PubMed     Abstract available


  62. SHIRAISHI T, Ogawa H, Kumasaka S, Shimoda Y, et al
    Comparison of Risk Factors for Locally Advanced Lower Rectal Cancer Recurrence Evaluated by Magnetic Resonance Imaging and Pathological Factors Analysed by Longitudinal Slicing Method.
    Anticancer Res. 2021;41:3169-3178.
    PubMed     Abstract available


    May 2021
  63. SUGITA A, Ikeuchi H, Funayama Y, Futami K, et al
    Postoperative Survival in Colitis-associated Colorectal Cancer With Ulcerative Colitis in Japan: A Multicenter Analysis.
    Anticancer Res. 2021;41:2681-2688.
    PubMed     Abstract available


  64. TAKAHASHI M, Sakamoto K, Irie T, Kawano S, et al
    Laparoscopic Surgery Is Acceptable for Elderly Patients With Colorectal Cancer: A Propensity Score-matched Study.
    Anticancer Res. 2021;41:2611-2615.
    PubMed     Abstract available


  65. SIGNORELLI C, Gemma D, Grande R, DE Marco S, et al
    Regorafenib-to-trifluridine/tipiracil Versus the Reverse Sequence for Refractory Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Real-life Experience.
    Anticancer Res. 2021;41:2553-2561.
    PubMed     Abstract available


  66. TAKABATAKE K, Arita T, Nakanishi M, Kuriu Y, et al
    Impact of Inferior Mesenteric Artery Lymph Node Metastasis on the Prognosis of Left-sided Colorectal Cancer.
    Anticancer Res. 2021;41:2533-2542.
    PubMed     Abstract available


  67. KITAMURA C, Sonoda H, Anzai H, Nagai Y, et al
    Expression of Lysophosphatidylinositol Signaling-relevant Molecules in Colorectal Cancer.
    Anticancer Res. 2021;41:2349-2355.
    PubMed     Abstract available


  68. NUMATA M, Tamagawa H, Kazama K, Atsumi Y, et al
    Potential Benefits of Minimally Invasive Laparoscopy in Reducing Local Recurrence After Surgery for Low Rectal Cancer.
    Anticancer Res. 2021;41:2617-2623.
    PubMed     Abstract available


  69. SHIBUTANI M, Kimura K, Kashiwagi S, Wang EN, et al
    Elevated Postoperative Levels of Serum C-reactive Protein Are Associated With Shorter Long-term Survival After Resection of Colorectal Liver Metastases, Regardless of the Occurrence of Infectious Complications.
    Anticancer Res. 2021;41:2605-2610.
    PubMed     Abstract available


  70. ELLIOT AH, Othman BN, Suzuki C, Blomqvist L, et al
    Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence.
    Anticancer Res. 2021;41:2459-2465.
    PubMed     Abstract available


  71. NORZ D, Mullins CS, Smit DJ, Linnebacher M, et al
    Combined Targeting of AKT and mTOR Synergistically Inhibits Formation of Primary Colorectal Carcinoma Tumouroids In Vitro: A 3D Tumour Model for Pre-therapeutic Drug Screening.
    Anticancer Res. 2021;41:2257-2275.
    PubMed     Abstract available


    April 2021
  72. NIISATO Y, Moriwaki T, Fukuoka S, Masuishi T, et al
    Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment.
    Anticancer Res. 2021;41:2203-2207.
    PubMed     Abstract available


  73. ISHIZAKI T, Mazaki J, Enomoto M, Shigoka M, et al
    Prospective Multicenter Phase II Study of Biweekly TAS-102 and Bevacizumab for Metastatic Colorectal Cancer.
    Anticancer Res. 2021;41:2157-2163.
    PubMed     Abstract available


  74. WATANABE T, Shiozawa M, Kimura Y, Hiroshima Y, et al
    Clinical Significance of Stanniocalcin2 mRNA Expression in Patients With Colorectal Cancer.
    Anticancer Res. 2021;41:2117-2122.
    PubMed     Abstract available


  75. SHIBA S, Shibuya K, Okamoto M, Okano N, et al
    Carbon-ion Radiotherapy for Oligometastatic Colorectal Cancer in the Liver or Lung.
    Anticancer Res. 2021;41:1997-2005.
    PubMed     Abstract available


  76. NISHINO H, Okuno M, Seo S, Toda R, et al
    Sinusoidal Obstruction Syndrome Promotes Liver Metastatic Seeding of Colorectal Cancer Cells in a Rat Model.
    Anticancer Res. 2021;41:1803-1810.
    PubMed     Abstract available


  77. MAEDA T, Konishi H, Takaki W, Takabatake K, et al
    Significance of Plasma UCA1 for Predicting Colorectal Cancer and BRAF Mutation Status.
    Anticancer Res. 2021;41:1761-1769.
    PubMed     Abstract available


  78. CARAVATTA L, Lupattelli M, Mantello G, Gambacorta MA, et al
    Treatment Volume, Dose Prescription and Delivery Techniques for Dose-intensification in Rectal Cancer: A National Survey.
    Anticancer Res. 2021;41:1985-1995.
    PubMed     Abstract available


  79. FIORI E, Crocetti D, Sapienza P, Miccini M, et al
    Colon or Rectal Stent Positioning for Advanced Cancer Influences Quality of Life: A Critical Point of View.
    Anticancer Res. 2021;41:1945-1950.
    PubMed     Abstract available


    March 2021
  80. SHIBUTANI M, En W, Okazaki Y, Maeda K, et al
    A High Postoperative Serum C-reactive Protein Level Has a Negative Impact on Long-term Survival, Regardless of Postoperative Infectious Complications, in Patients Who Undergo Laparoscopic Surgery for Colorectal Cancer.
    Anticancer Res. 2021;41:1593-1598.
    PubMed     Abstract available


  81. PACZEK S, Lukaszewicz-Zajac M, Gryko M, Kulczynska-Przybik A, et al
    The Clinical Utility of Serum CXCR-2 Assessment in Colorectal Cancer (CRC) Patients.
    Anticancer Res. 2021;41:1421-1428.
    PubMed     Abstract available


  82. MO S, Ku HJ, Choi SH, Jeong HJ, et al
    470 nm LED Irradiation Inhibits the Invasiveness of CD133-positive Human Colorectal Cancer Stem Cells by Suppressing the Cyclooxygenase-2/prostaglandin E2 Pathway.
    Anticancer Res. 2021;41:1407-1420.
    PubMed     Abstract available


  83. TERASAKI M, Hamoya T, Kubota A, Kojima H, et al
    Fucoxanthin Prevents Colorectal Cancer Development in Dextran Sodium Sulfate-treated Apc (Min/+) Mice.
    Anticancer Res. 2021;41:1299-1305.
    PubMed     Abstract available


  84. ASADA Y, Tsuruta M, Okabayashi K, Shigeta K, et al
    Inhibition of Heat-shock Protein 27 Reduces 5-Fluorouracil-acquired Resistance in Human Colon Cancer Cells.
    Anticancer Res. 2021;41:1283-1290.
    PubMed     Abstract available


  85. WANG S, Wang X, Wang YU, Leng Q, et al
    The Anti-oxidant Monoterpene p-Cymene Reduced the Occurrence of Colorectal Cancer in a Hyperlipidemia Rat Model by Reducing Oxidative Stress and Expression of Inflammatory Cytokines.
    Anticancer Res. 2021;41:1213-1218.
    PubMed     Abstract available


  86. AGAWA K, Matsuda T, Yamashita K, Hasegawa H, et al
    Feasibility and Safety of Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiotherapy for Elderly Patients With Locally Advanced Rectal Cancer.
    Anticancer Res. 2021;41:1677-1682.
    PubMed     Abstract available


  87. HIROSE Y, Sakata J, Kobayashi T, Miura K, et al
    NQO1 as a Marker of Chemosensitivity and Prognosis for Colorectal Liver Metastasis.
    Anticancer Res. 2021;41:1563-1570.
    PubMed     Abstract available


  88. RUBIO CA, Schmidt PT
    Nondysplastic Crypts in Fission in Nonpolypoid Adenomas and in the Adjacent Mucosa Support Field Cancerization in the Colon.
    Anticancer Res. 2021;41:1515-1521.
    PubMed     Abstract available


  89. FINDLEN UM, Belt RL, Fan L, Bridges N, et al
    Hearing Status of Children and Adolescents With Familial Adenomatous Polyposis.
    Anticancer Res. 2021;41:1439-1444.
    PubMed     Abstract available


  90. TOKUDA A, Miyake T, Yasukawa D, Ikuta D, et al
    Cancer-derived Exosomes Activate Immune Surveillance and Suppress Peritoneal Metastasis of Murine Colonic Cancer.
    Anticancer Res. 2021;41:1327-1339.
    PubMed     Abstract available


    February 2021
  91. PIAN G, Shin JS, Yoon S, Oh SY, et al
    Prognostic Reappraisal of Postoperative Carcinoembryonic Antigen in T1-2N0 Colorectal Cancer.
    Anticancer Res. 2021;41:1101-1110.
    PubMed     Abstract available


  92. KOSUMI K, Mima K, Morito A, Yumoto S, et al
    Patient Age and Long-term Survival in Colorectal Cancer Patients Who Undergo Emergency Surgery.
    Anticancer Res. 2021;41:1069-1076.
    PubMed     Abstract available


  93. NAKASHIMA M, Takeuchi M, Tanaka S, Kawakami K, et al
    Salvage Therapy After Regorafenib or Trifluridine/Tipiracil Treatment of Metastatic Colorectal Cancer: A Conditional Landmark Analysis.
    Anticancer Res. 2021;41:1055-1062.
    PubMed     Abstract available


  94. OBARA N, Hirano Y, Ishii T, Kondo H, et al
    Laparoscopic Surgery for Colorectal Cancer in Patients on Hemodialysis: A Propensity Score-matched Analysis.
    Anticancer Res. 2021;41:993-997.
    PubMed     Abstract available


  95. NAKAMURA M, Kageyama SI, Seki M, Suzuki A, et al
    Liquid Biopsy Cell-free DNA Biomarkers in Patients With Oligometastatic Colorectal Cancer Treated by Ablative Radiotherapy.
    Anticancer Res. 2021;41:829-834.
    PubMed     Abstract available


  96. PAPADIMITRIOU M, Papadimitriou CA
    Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib.
    Anticancer Res. 2021;41:567-582.
    PubMed     Abstract available


    January 2021
  97. HUANG RH, Yang WK, Wu CM, Yeh CM, et al
    Over-expression of CEP55 Predicts Favorable Prognosis in Colorectal Cancer Patients With Lymph Node Involvement.
    Anticancer Res. 2021;41:543-547.
    PubMed     Abstract available


  98. YAMADA Y, Matsuhashi N, Fujii H, Makiyama A, et al
    Impact of Anti-angiogenic Agents on Chemotherapy Efficacy in Patients With Metastatic Colorectal Cancer: Second-line FOLFIRI Plus Bevacizumab or Aflibercept.
    Anticancer Res. 2021;41:533-541.
    PubMed     Abstract available


  99. PODGORSKA M, Pietraszek-Gremplewicz K, OlszaNska J, Nowak D, et al
    The Role of Apelin and Apelin Receptor Expression in Migration and Invasiveness of Colon Cancer Cells.
    Anticancer Res. 2021;41:151-161.
    PubMed     Abstract available


  100. THADI A, Morano WF, Khalili M, Babcock BD, et al
    Molecular Targeting of H/MDM-2 Oncoprotein in Human Colon Cancer Cells and Stem-like Colonic Epithelial-derived Progenitor Cells.
    Anticancer Res. 2021;41:27-42.
    PubMed     Abstract available


  101. SCHEIPNER L, Smolle MA, Barth D, Posch F, et al
    The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma.
    Anticancer Res. 2021;41:429-436.
    PubMed     Abstract available


    December 2020
  102. KIMURA M, Usami E, Yoshimura T
    Effects of Type of Antibody to EGFR and Hypomagnesemia on Overall Survival in First-line Treatment of Patients With Unresectable Advanced/Recurrent Colorectal Cancer.
    Anticancer Res. 2020;40:7135-7140.
    PubMed     Abstract available


  103. AHMED A, Halama N
    Differential Analyses of Peripheral Blood Parameters in CCR5 Inhibition-treated Colorectal Cancer Patients Reveal Dynamic Changes Linked to Clinical Outcomes.
    Anticancer Res. 2020;40:6933-6939.
    PubMed     Abstract available


  104. ANNICCHIARICO A, Morini A, Romboli A, RiccO M, et al
    Stage III and Metastatic Lymph Node Ratio Are the only Independent Prognostic Factors in Colorectal Signet-ring Cell Carcinoma Patients.
    Anticancer Res. 2020;40:7127-7134.
    PubMed     Abstract available


  105. LIU B, Shiraga S, Mortenson MM, Lai J, et al
    Small Cell Lung Carcinoma and Synchronous Rectal Adenocarcinoma and Jejunal Gastrointestinal Stromal Tumor Present in a Patient With History of Laryngeal Squamous Cell Carcinoma.
    Anticancer Res. 2020;40:7053-7056.
    PubMed     Abstract available


  106. VODICKA J, Fichtl J, Sebek J, ProchAzkovA K, et al
    Outcomes and Prognostic Factors Following Surgical Treatment of Pulmonary Metastases from Colorectal Carcinoma.
    Anticancer Res. 2020;40:7045-7051.
    PubMed     Abstract available


  107. YAMAMOTO J, Sugisawa N, Hamada K, Nishino H, et al
    A Universal Gelfoam 3-D Histoculture Method to Establish Patient-derived Cancer Cells (3D-PDCC) Without Fibroblasts from Patient-derived Xenografts.
    Anticancer Res. 2020;40:6765-6768.
    PubMed     Abstract available


  108. PALEK R, Rosendorf J, Maleckova A, Vistejnova L, et al
    Influence of Mesenchymal Stem Cell Administration on The Outcome of Partial Liver Resection in a Porcine Model of Sinusoidal Obstruction Syndrome.
    Anticancer Res. 2020;40:6817-6833.
    PubMed     Abstract available


    November 2020
  109. AHMED A, Halama N
    Tertiary Lymphoid Structures in Colorectal Cancer Liver Metastases: Association With Immunological and Clinical Parameters and Chemotherapy Response.
    Anticancer Res. 2020;40:6367-6373.
    PubMed     Abstract available


  110. NGAMKHAM J, Thuwajit C, Thuwajit P, Khamwachirapithak P, et al
    Overexpression of Pyruvate Carboxylase Is Correlated With Colorectal Cancer Progression and Supports Growth of Invasive Colon Cancer HT-29 Cell Line.
    Anticancer Res. 2020;40:6285-6293.
    PubMed     Abstract available


  111. LIN PM, Lee HM, Huang CI, Tai TS, et al
    Synergistic Antiproliferative Effect of Ribociclib (LEE011) and 5-Fluorouracil on Human Colorectal Cancer.
    Anticancer Res. 2020;40:6265-6271.
    PubMed     Abstract available


  112. MUSA M, Ouaret D, Bodmer WF
    In Vitro Analyses of Interactions Between Colonic Myofibroblasts and Colorectal Cancer Cells for Anticancer Study.
    Anticancer Res. 2020;40:6063-6073.
    PubMed     Abstract available


  113. NAGATA M, Matsuda T, Hasegawa H, Utsumi M, et al
    Usefulness of Omentoplasty to Reduce Perineal Wound Complications in Abdominoperineal Resection After Neoadjuvant Chemoradiotherapy.
    Anticancer Res. 2020;40:6539-6543.
    PubMed     Abstract available


  114. RYU S, Okamoto A, Nakashima K, Hara K, et al
    Usefulness of Preoperative Endoscopic Fluorescent Clip Marking in Laparoscopic Gastrointestinal Surgery.
    Anticancer Res. 2020;40:6517-6523.
    PubMed     Abstract available


  115. HUANG WL, Luo CW, Chou CL, Yang CC, et al
    High Expression of UBE2B as a Poor Prognosis Factor in Patients With Rectal Cancer Following Chemoradiotherapy.
    Anticancer Res. 2020;40:6305-6317.
    PubMed     Abstract available


    October 2020
  116. GO G, Yun CW, Yoon YM, Lim JH, et al
    Role of PrP(C) in Cancer Stem Cell Characteristics and Drug Resistance in Colon Cancer Cells.
    Anticancer Res. 2020;40:5611-5620.
    PubMed     Abstract available


  117. YAMADA Y, Yoshimatsu K, Yokomizo H, Okayama S, et al
    Expression of ATP-binding Cassette Transporter 11 (ABCC11) Protein in Colon Cancer.
    Anticancer Res. 2020;40:5405-5409.
    PubMed     Abstract available


  118. JONSSON G, Philipson L, Villman K, Valachis A, et al
    Upfront Radiotherapy in Patients With Asymptomatic Incurable Rectal Cancer: A Retrospective Cohort Study.
    Anticancer Res. 2020;40:5853-5860.
    PubMed     Abstract available


  119. ANGELOU A, Papalois AE, Antoniou E, Wang J, et al
    The Interplay Between Innate Immunity (TLR-4) and sCD40L in the Context of an Animal Model of Colitis-associated Cancer.
    Anticancer Res. 2020;40:5457-5462.
    PubMed     Abstract available


  120. YIN F, Xie H, Lai J, Chen Y, et al
    Double Negativity for Expression of YAP1 and CDX2 Defines an Aggressive Type of Colitis-associated Cancer.
    Anticancer Res. 2020;40:5411-5416.
    PubMed     Abstract available


  121. JIA JB, Ling X, Xing M, Ludwig JM, et al
    Novel TSPO-targeted Doxorubicin Prodrug for Colorectal Carcinoma Cells.
    Anticancer Res. 2020;40:5371-5378.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: